MedPath
NMPA Approval

Ethambutol Hydrochloride,Pyrazinamide,Rifampicin and Isoniazid Tablets(Ⅱ)

国药准字H20110094

January 18, 2021

国药准字H20110094

Drug Information

乙胺吡嗪利福异烟片(Ⅱ)

片剂

450mg(C43H58N4O12 75mg、C6H7N3O 37.5mg、C5H5N3O 200mg和C10H24N2O2·2HCl 137.5mg)

化学药品

January 18, 2021

Company Information

Applicant Company

浙江省杭州市钱塘区前进街道长福杭路829号

Manufacturing Company

浙江省杭州市钱塘区前进街道长福杭路829号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.